On-Label Versus Off-Label Use of Recombinant Activated Factor VII: A Comprehensive Review of Use in Two Canadian Centers
Author:
Publisher
Elsevier BV
Subject
Hematology
Reference11 articles.
1. Recombinant factor VIIa as adjunctive therapy for bleeding control in severely injured trauma patients: Two parallel randomized, placebo-controlled, double-blind clinical trials;Boffard;J Trauma,2005
2. Recombinant activated factor VII for acute intracerebral hemorrhage;Mayer;N Engl J Med,2005
3. Recombinant FVIIa decreases perioperative blood transfusion requirement in burn patients undergoing excision and skin grafting—Results of a single centre pilot study;Johansson;Burns,2007
4. Recombinant activated factor VII in cardiac surgery: A systematic review;Warren;Ann Thorac Surg,2007
5. Effect of recombinant activated factor VII on perioperative blood loss in patients undergoing retropubic prostatectomy: A double-blind placebo-controlled randomised trial;Friederich;Lancet,2003
Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Off-Label Use of Recombinant Factor VIIa in U.S. Hospitals: Analysis of Hospital Records;Annals of Internal Medicine;2011-04-19
2. Recombinant Factor VIIa: An Assessment of Evidence Regarding Its Efficacy and Safety in the Off-Label Setting;Hematology;2010-12-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3